Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 40.65
-0.35 (-0.85%)
Sep 8, 2026, 1:30 PM CST
Qing Song Health Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,712 | 4,161 | 5,879 | 4,581 | 2,077 | - | |
Market Cap Growth | -17.34% | -29.22% | 28.33% | 120.52% | - | - |
Enterprise Value | 3,034 | 4,589 | 6,652 | 5,047 | 2,559 | - |
Last Close Price | 41.00 | 62.41 | 95.81 | 74.59 | 33.81 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.91 | 45.37 | 144.98 | 77.13 | 89.05 | - |
PS Ratio | 2.24 | 3.71 | 5.98 | 5.27 | 3.26 | - |
PB Ratio | 2.04 | 3.56 | 8.75 | 6.97 | 3.49 | - |
P/TBV Ratio | 2.09 | 3.64 | 9.10 | 7.40 | 3.71 | - |
P/FCF Ratio | - | - | 47.74 | - | 59.62 | - |
P/OCF Ratio | - | - | 28.00 | 212.12 | 15.96 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.50 | 4.09 | 6.77 | 5.81 | 4.02 | - |
EV/EBITDA Ratio | 13.14 | 36.23 | 61.21 | 46.12 | 37.76 | - |
EV/EBIT Ratio | 36.08 | 80.47 | 150.93 | 94.30 | 178.73 | - |
EV/FCF Ratio | - | - | 54.02 | - | 73.44 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.93 | 1.03 | 1.67 | 1.33 | 1.36 | 1.24 |
Debt / EBITDA Ratio | 5.37 | 6.05 | 6.47 | 5.36 | 7.40 | 10.27 |
Debt / FCF Ratio | - | - | 9.13 | - | 23.23 | 50.16 |
Net Debt / Equity Ratio | 0.22 | 0.32 | 1.06 | 0.73 | 0.76 | 0.71 |
Net Debt / EBITDA Ratio | 1.87 | 2.90 | 6.56 | 4.35 | 6.70 | 10.35 |
Net Debt / FCF Ratio | -1.09 | -2.42 | 5.79 | -21.40 | 13.02 | 28.73 |
Asset Turnover | 0.46 | 0.49 | 0.54 | 0.54 | 0.44 | 0.28 |
Inventory Turnover | 1341.88 | 1364.25 | 1792.78 | 1907.97 | 260.49 | 97.42 |
Quick Ratio | 4.17 | 3.90 | 1.81 | 2.44 | 2.27 | 2.75 |
Current Ratio | 4.20 | 3.93 | 1.83 | 2.46 | 2.28 | 2.80 |
Return on Equity (ROE) | 21.29% | 10.17% | 6.13% | 9.39% | 3.21% | 0.04% |
Return on Assets (ROA) | 1.99% | 1.57% | 1.51% | 2.07% | 0.62% | -0.19% |
Return on Invested Capital (ROIC) | 4.82% | 3.27% | 2.81% | 3.65% | 0.96% | -0.43% |
Return on Capital Employed (ROCE) | 3.30% | 2.40% | 2.60% | 3.60% | 1.00% | -0.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.18% | 2.20% | 0.69% | 1.30% | 1.12% | - |
FCF Yield | -9.77% | -3.66% | 2.10% | -0.49% | 1.68% | - |
Dividend Yield | 1.17% | - | 0.50% | 0.11% | - | - |
Payout Ratio | 25.50% | 43.28% | 12.25% | 1.79% | - | - |
Buyback Yield / Dilution | -5.32% | -9.86% | 0.01% | -0.01% | -0.01% | -15.91% |
Total Shareholder Return | -4.14% | -9.86% | 0.51% | 0.10% | -0.01% | -15.91% |